Frontlight ResearchEarly access
Trial site
Sarah Cannon Research Institute (SCRI) Oncology Partners
- 6running trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- Colorectal cancer2 trials
- Ovarian cancer2 trials
- Pancreatic cancer2 trials
- Bladder cancer1 trial
- Endometrial cancer1 trial
- Gastric and oesophageal cancer1 trial
- Head and neck cancer1 trial
- Liver and biliary tract cancer1 trial
- Melanoma1 trial
- Prostate cancer1 trial
- Sarcoma1 trial
- Phase
- Phase 13 trials
- Phase 32 trials
- Phase 21 trial
- Status
- Recruiting3 trials
- Not yet recruiting2 trials
- Active, not recruiting1 trial
- Lead sponsor
- Clasp Therapeutics, Inc.2 trials
- Regeneron Pharmaceuticals2 trials
- Akeso1 trial
- Pheast Therapeutics1 trial
Running trials
Recruiting
Not yet recruiting
A Study of CLSP 5282 in HLA-A*03:01 Positive Adult Patients With Solid Tumors (SENTINEL-101)
Recruiting
Recruiting
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer2 recruiting
- Lung cancer2 recruiting
- Ovarian cancer2 recruiting
- Pancreatic cancer2 recruiting
- Bladder cancer1 recruiting
- Endometrial cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Head and neck cancer1 recruiting
- Liver and biliary tract cancer1 recruiting
- Melanoma1 recruiting
- Prostate cancer1 recruiting
- Sarcoma1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026